Clinical trial
A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5…
NCT00457626 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00457626 |
|---|---|
| Title | A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension |
| Official title | An Open Label Extension Study to Evaluate Safety, Tolerability, and Efficacy of 18 Weeks of Valsartan Treatment in Children 6 Months-5 Years Old With Hypertension |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Valsartan |
| Enrollment | 66 |
| Start date | Apr 9, 2007 |
| Primary completion | May 25, 2009 |
| Completion | May 25, 2009 |
| First posted | Apr 6, 2007 |
| Last update posted | Sep 5, 2021 |
| Countries | Belgium, Brazil, France, Hungary, India, Italy, Poland, South Africa, Turkey (Türkiye), United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: